# US 2025/0082245 A1 · Method and apparatus for wide-band phase gradient signal acquisition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082245 A1
- Document ID: US20250082245A1
- Status: Published application
- Kind: A1
- Application number: 18/744,902
- Filed: 2024-06-17
- Published: 2025-03-13
- Earliest claimed: 2015-08-26
- Assignees: Analytics For Life Inc.
- Applicants: Analytics For Life Inc.
- Inventors: Sunny Gupta; Don Crawford; Timothy William Fawcett Burton; Shyamlal Ramchandani; Kristine Canavan
- Web page: https://patentgrep.com/patent/US20250082245A1

## CPC

- A61B 5/308: for electrocardiography [ECG]
- A61B 5/0006: {ECG or EEG signals}
- A61B 5/14551: {for measuring blood gases}
- A61B 5/31: for electroencephalography [EEG]
- A61B 5/346: Analysis of electrocardiograms
- A61B 5/282: Holders for multiple electrodes (for introduction into the body A61B5/287)
- A61B 5/301: providing electrical separation, e.g. by using isolating transformers or optocouplers
- A61B 5/332: Portable devices specially adapted therefor
- A61B 5/7203: {for noise prevention, reduction or removal}
- A61B 5/7225: {Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation (input circuits for detecting, measuring, or recording bioelectric or biomagnetic signals A61B5/30; specific diagnostic methods using bioelectric or biomagnetic signals A61B5/316)}
- A61B 5/725: {using specific filters therefor, e.g. Kalman or adaptive filters (specific diagnostics methods using using bioelectric or biomagnetic signals A61B5/316)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

The present disclosure facilitates capture of biosignal such as biopotential signals in microvolts, or sub-microvolts, resolutions that are at, or significantly below, the noise-floor of conventional electrocardiographic and biosignal acquisition instruments. In some embodiments, the exemplified system disclosed herein facilitates the acquisition and recording of wide-band phase gradient signals (e.g., wide-band cardiac phase gradient signals, wide-band cerebral phase gradient signals) that are simultaneously sampled, in some embodiments, having a temporal skew less than about 1 μs, and in other embodiments, having a temporal skew not more than about 10 femtoseconds. Notably, the exemplified system minimizes non-linear distortions (e.g., those that can be introduced via certain filters) in the acquired wide-band phase gradient signal so as to not affect the information therein.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A system configured to prevent self-interference from communication hardware associated with a biopotential acquisition subsystem that captures wide-band cardiac phase gradient signal data, the system comprising:
the biopotential acquisition subsystem comprising two or more biosignal acquisition channels, each biosignal acquisition channel comprising a gain amplifier configured to amplify biopotential signals having a signal level less than about 5 mV received from one or more surface electrodes placed on a patient to generate a wide-band cardiac phase gradient signal; and
a wireless communication subsystem comprising an antenna and a transceiver, the transceiver being configured to transmit, via the antenna, data stream associated with the wide-band cardiac phase gradient signal to a remote computing device,
wherein the wireless communication subsystem is configured to disable transmission of electromagnetic radiation over the antenna when the biopotential acquisition subsystem is acquiring the wide-band cardiac phase gradient signal, and
wherein the wireless communication subsystem is configured to enable transmission of electromagnetic radiation immediately following acquisition of the wide-band cardiac phase gradient signal by the biopotential acquisition subsystem.

### Claim 25 (depends on 24)

The system of claim 24, wherein the wireless communication subsystem comprises a transmitter selected from the group consisting of a Wi-Fi transmitter, a cellular data service transmitter, a mobile satellite communication service transmitter, and a short-range point-to-point communication transmitter.

### Claim 26 (depends on 24)

The system of claim 24, wherein the wireless communication subsystem is configured to actively drive the patient's body to a varying potential that shunts environmental noise currents flowing in the patient's body.

### Claim 27 (depends on 26)

The system of claim 26, wherein a substantial portion of the varying potential is negative.

### Claim 28 (depends on 26)

The system of claim 26, wherein the varying potential varies between two negative potential values.

### Claim 29 (depends on 28)

The system of claim 28, wherein a respective magnitude of each negative potential value is greater than an expected half-cell potential direct current (DC) bias value associated with the surface electrodes.

### Claim 30 (depends on 24)

The system of claim 24, wherein the wireless communication subsystem actively drives the patient to an alternating potential having a minimum magnitude greater than a DC bias value associated with the one or more of the surface electrodes placed on the patient.

### Claim 31 (depends on 24)

The system of claim 24, further comprising:
a noise rejection system configured to actively shield a signal-carrying conductor in a cable between a common-mode surface electrode and the noise rejection system.

### Claim 32 (depends on 31)

The system of claim 31, wherein the noise rejection system comprises a waveform generator and an operational amplifier.

### Claim 33 (depends on 32)

The system of claim 32, wherein the waveform generator is an electronically programmable microcontroller that is configured to generate an analog output that can vary in frequency and amplitude range.

### Claim 34 (depends on 31)

The system of claim 31, wherein the noise rejection system actively drives the patient's body to a constant potential value so as to shunt environmental noise currents flowing in the patient's body.

### Claim 35 (depends on 34)

The system of claim 34, wherein the constant potential value is between −1.5 VDC and +3 VDC.

### Claim 36

A method for preventing self-interference from communication hardware associated with a biopotential acquisition subsystem that captures wide-band cardiac phase gradient signal data, the method comprising:
acquiring, by the biopotential acquisition subsystem, a wide-band cardiac phase gradient signal, wherein the biopotential acquisition subsystem comprises two or more biosignal acquisition channels, each biosignal acquisition channel comprising a gain amplifier configured to amplify biopotential signals having a signal level less than about 5 mV received from one or more surface electrodes placed on a patient;
transmitting, by a wireless communication subsystem, a data stream associated with the wide-band cardiac phase gradient signal to a remote computing device;
disabling, by the wireless communication subsystem, transmission of electromagnetic radiation over an antenna of the wireless communication subsystem when the biopotential acquisition subsystem is acquiring the wide-band cardiac phase gradient signal; and
enabling, by the wireless communication subsystem, transmission of electromagnetic radiation immediately following acquisition of the wide-band cardiac phase gradient signal by the biopotential acquisition subsystem.
